Trial intelligence / Profile preview

PRP versus triamcinolone for meniscal injuries

ACTRN12614001016628Phase 2Recruiting

Sponsor
Combined Military Hospital
Start
Jul 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 2, open-label trial of platelet-rich plasma and triamcinolone acetonide in meniscal tear (2 arms), sponsored by Combined Military Hospital. Primary endpoint: Knee pain by Visual analogue scale. Started Jul 2014; status: recruiting.

02

Drugs

platelet-rich plasmatriamcinolone acetonide
03

Conditions

meniscal tear

Beyond the preview

Go deeper on ACTRN12614001016628.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12614001016628.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call